Fortis Healthcare Limited (NSE:FORTIS)
India · Delayed Price · Currency is INR 915.00
+7.00 (0.77%)
At close: Sep 9, 2026
Fortis Healthcare Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Fortis Healthcare stock has a consensus rating of "Strong Buy" and an average price target of ₹1,116. The average 1-year stock price forecast is 21.95% higher than the current stock price, while the lowest is ₹975.00 (+6.56%) and the highest is ₹1,180 (+28.96%).
Price Target: ₹1,116 (+21.95%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 11, 2026.
Analyst Ratings
The average analyst rating for Fortis Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 12 | 13 | 14 | 16 |
| Buy | 2 | 2 | 3 | 3 | 3 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 18 | 18 | 19 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains ₹1,180 | Buy | Maintains | ₹1,180 | +28.96% | Aug 11, 2026 |
| Geojit Research | Geojit Research | Buy Reiterates ₹1,150 | Buy | Reiterates | ₹1,150 | +25.68% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
106.34B
from 91.28B
Increased by 16.50%
Revenue Next Year
122.64B
from 106.34B
Increased by 15.32%
EPS This Year
17.11
from 14.03
Increased by 21.96%
EPS Next Year
22.80
from 17.11
Increased by 33.23%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.